Uro-oncology deals with cancers of the urinary system and male reproduction system. These include cancer of kidney, adrenal gland, ureter, bladder, prostate, urethra, penis and testis. Our centre offer comprehensive management of these cancers.
Prostate cancer is the commonest cancer in men in both America and Europe. In Singapore, it is the fastest increasing cancer with the latest survey showing it to be the third most common cancer in Singapore men.
Kidney cancer is also on the rise with incidence doubling in the last 35 years in Singapore. Both kidney and bladder cancers are much more common in men than women. Bladder cancer is also one of the ten most common cancers in Singapore, having a strong association with smoking and aging.
Testis cancer is less common but affects younger men. In fact, it is the most common cancer in a man between the ages of 17 to 34 years old.
Treatment of uro oncology conditions have improved dramatically in the last decade. Many cancers are diagnosed in the early stage and surgical removal of the organ or part of the organ has given the patient a chance of cure. Surgical techniques have improved with the advancement in laparoscopy surgery (key hole surgery), endoscopy surgery (scope surgery without a surgical cut) and robotic assisted surgery. Hence, surgical outcomes are much better; causes less pain and quicker recovery for the patient.
As a result of extensive medical research, we have a better understanding of cancer behavior and are able to fine tune our treatment to each cancer, giving the optimal result. This has necessitated the close collaboration between the urologist (urology surgeon and usually the main doctor), medical oncologist and radiation oncologist.
Cancers with previously poor outcomes have been successfully treated with a combination of planned surgery followed by chemotherapy or radiation. Our centre emphasizes on this close collaboration and pooling of expertise in the management of urology oncology conditions.